BY-HEALTH CO., LTD
Research BY-HEALTH CO., LTD (300146.SZ) on Bullrun: market cap CNY 17.24B, P/E 24.3, dividend yield 4.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker300146.SZ
- ExchangeSZ
- CountryChina
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyCNY
- Market capCNY 17.24B
- P/E24.3
- Dividend yield4.4%
- Financial periodQ2 2026
- RevenueCNY 1.80B
- Net incomeCNY 201.42M
- Free cash flowCNY 94.29M
- Gross margin71.6%
Valuation Snapshot
latest market cap is CNY 17.24B; P/E is 24.3; dividend yield is 4.4%.
Peer valuation comparison
Latest P/E is 24.26x versus a Consumer Defensive sector median of 16.8x (44.4% above).
Latest dividend yield is 4.43% versus a Consumer Defensive sector median of 2.98% (48.7% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | CNY 17.24B | 24.3 | 4.3% | 0.45 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.45 CNY, yield 4.4%.
About BY-HEALTH CO., LTD
Byhealth Co., Ltd, together with its subsidiaries, provides dietary supplements in China, Hong Kong, Australia, and internationally. It offers protein powder; collagen; bone health products, including glucosamine, chondroitin, and calcium tablets; probiotics; capsules; and multivitamins under the By-Health, Jianlidu, LifeSpace, and other brand names. The company also engages in scenic area tourism management; real estate; trade and investment; sale of food; trademark management;
ETFs that hold BY-HEALTH CO., LTD
US-listed ETFs
BY-HEALTH CO., LTD is held by 19 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
| Schwab Emerging Markets Equity ETF (SCHE) | <0.01% | 0.06% |
| Vanguard International High Dividend Yield Index Fund ETF Shares (VYMI) | <0.01% | 0.07% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is BY-HEALTH CO., LTD's market cap?
BY-HEALTH CO., LTD's market capitalization is CNY 17.24B.
What is BY-HEALTH CO., LTD's P/E ratio?
BY-HEALTH CO., LTD's price-to-earnings (P/E) ratio is 24.3.
Does BY-HEALTH CO., LTD pay a dividend?
BY-HEALTH CO., LTD has a dividend yield of 4.4%.
What does BY-HEALTH CO., LTD do?
Byhealth Co., Ltd, together with its subsidiaries, provides dietary supplements in China, Hong Kong, Australia, and internationally. It offers protein powder; collagen; bone health products, including glucosamine, chondroitin, and calcium tablets; probiotics; capsules; and multivitamins under the By-Health, Jianlidu, LifeSpace, and other brand names. The company also engages in scenic area tourism management; real estate; trade and investment; sale of food; trademark management; and OTC licensing and outsourced processing activities.